Clinical trial
Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
NCT00016523 · NICHD Neonatal Research Network, Other · Terminated
Key facts
| NCT number | NCT00016523 |
|---|---|
| Title | Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure |
| Official title | Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure |
| Acronym | Preemie iNO |
| Lead sponsor | NICHD Neonatal Research Network, Other |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infant, Newborn, Low Birth Weight, Small for Gestational Age, Premature, Respiratory Distress Syndrome (RDS), Sepsis, Pneumonia, Hypertension, Pulmonary |
| Intervention type | Drug |
| Interventions | Inhaled nitric oxide, Placebo |
| Enrollment | 420 |
| Start date | Jan 1, 2001 |
| Primary completion | Sep 1, 2003 |
| Completion | May 1, 2006 |
| First posted | May 16, 2001 |
| Last update posted | Sep 26, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: